PU
PURE Bioscience, Inc.
PURE · OTC
$0.07 +0.00% (+$0.00)
1M -19.33%
Market Cap $7.87M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0.07
0.0% downside
Trenutna cena
$0.07
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica PURE trenutno podcenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
3/9Valuation
8 /100
Expensive EV/EBITDA 72.33x
P/S 3.25x
P/E N/A
Growth
65 /100
Stable Rev. growth 5.92%
EPS growth N/A
FCF growth N/A
Profitability
20 /100
Weak Gross margin 53,803.60%
Net margin 91.04%
Op. margin 79.11%
Quality
21 /100
Poor ROIC 291.19%
ROA 141.53%
Asset turnover 1.55x
Debt
0 /100
High Current ratio 0.42x
Int. coverage -0.01x
Net debt/EBITDA 29.81x
Stability
62 /100
Moderate Beta 0.23x
Rev. volatility 5.58%
EPS volatility 9.55%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o PURE
Online
Sector
Basic Materials
Industry
Chemicals
CEO
Jeff Kitchell
Employees
12
Headquarters
El Cajon